Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qualigen Therapeutics, Inc.

3.53
+0.29008.95%
Volume:9.72K
Turnover:33.05K
Market Cap:2.60M
PE:-0.08
High:3.53
Open:3.21
Low:3.20
Close:3.24
Loading ...

Qualigen Seeks to Enter the $10 Billion Cabg Market With Non-Binding Mou to Acquire Marizyme

THOMSON REUTERS
·
01 Apr

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme

GlobeNewswire
·
01 Apr

Qualigen Therapeutics: Will Be First Investors Participating in 2025 Bridge Round of Funding for Nanosynex

THOMSON REUTERS
·
28 Jan

Qualigen to participate in next funding round for NanoSynex

GlobeNewswire
·
28 Jan

Qualigen Therapeutics Regains Compliance With Nasdaq's Minimum Bid Price, Equity Rules

MT Newswires Live
·
06 Dec 2024

Qualigen Therapeutics regains compliance with Nasdaq’s min bid price

TIPRANKS
·
05 Dec 2024

Qualigen Therapeutics Announces Regained Compliance With Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

THOMSON REUTERS
·
05 Dec 2024

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

GlobeNewswire
·
05 Dec 2024

BRIEF-Univest Securities Announces Successful Closing Of $5.1 Million Private Placement For Qualigen Therapeutics

Reuters
·
26 Nov 2024

Univest Securities, Llc Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (Nasdaq: Qlgn)

THOMSON REUTERS
·
26 Nov 2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

GlobeNewswire
·
26 Nov 2024

BRIEF-Qualigen Therapeutics Announces $4.5 Million Private Placement Of Convertible Preferred Shares

Reuters
·
19 Nov 2024

Qualigen Therapeutics Inc: Announces $4.5 Mln Private Placement of Convertible Preferred Shares

THOMSON REUTERS
·
19 Nov 2024

Qualigen announces $4.5M private placement of Preferred Shares

TIPRANKS
·
19 Nov 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

GlobeNewswire
·
19 Nov 2024

Qualigen Therapeutics trading halted, news pending

TIPRANKS
·
05 Nov 2024

BRIEF-Qualigen Therapeutics - Will Implement A 1-For-50 Reverse Stock Split Of Issued Shares Of Its Common Stock

Reuters
·
01 Nov 2024

Qualigen Therapeutics - Will Implement a 1-for-50 Reverse Stock Split of Issued Shares of Its Common Stock

THOMSON REUTERS
·
01 Nov 2024

Qualigen Therapeutics - Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

THOMSON REUTERS
·
01 Nov 2024

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

GlobeNewswire
·
01 Nov 2024